ArticleFrontiers in oncology2022

Development and Characterization of an HCMV Multi-Antigen Therapeutic Vaccine for Glioblastoma Using the UNITE Platform.

Amit S Adhikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.